Evidence map›Paper›PMID 36735910›Full record

ArticleBlood2023

Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A.

Pedro Gonzalez-Menendez, Ira Phadke, Meagan E Olive, Axel Joly, Julien Papoin, Hongxia Yan, Jérémy Galtier, Jessica Platon, Sun Woo Sophie Kang, Kathy L McGraw and 23 more

Open access · greenAbstract read
In one paragraph

Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Microbiome-derived metabolites in cancer-associated anemia: An underexplored mechanistic link.World journal of gastrointestinal pharmacology and therapeutics · 2025
    Article
  11. mRNA translational control of regeneration.Current opinion in genetics & development · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 14 institutions in 3 countries.

Pedro Gonzalez-MenendezInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.ORCID 0000-0003-3114-6304
Ira PhadkeInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.ORCID 0000-0002-0735-4333
Meagan E OliveProteomics Platform, Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA.ORCID 0000-0001-8287-9474
Axel JolyInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
Julien PapoinFeinstein Institute for Medical Research, Manhasset, NY.ORCID 0000-0002-5446-6469
Hongxia YanNew York Blood Center, New York, NY.ORCID 0000-0002-8187-2788
Jérémy GaltierInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
Jessica PlatonEA4666 HEMATIM, Université Picardie Jules Verne, Amiens, France.
Sun Woo Sophie KangThoracic and GI Malignancies Branch, NCI, CCR, NIH, Bethesda, MD.
Kathy L McGrawLaboratory of Receptor Biology and Gene Expression, NCI, CCR, NIH, Bethesda, MD.ORCID 0000-0001-9184-5399
Marie DaumurInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
Marie PouzollesPediatric Oncology Branch, National Cancer Institute (NCI), Center for Cancer Research (CCR), National Institutes of Health (NIH), Bethesda, MD.ORCID 0000-0003-1808-820X
Taisuke KondoPediatric Oncology Branch, National Cancer Institute (NCI), Center for Cancer Research (CCR), National Institutes of Health (NIH), Bethesda, MD.ORCID 0000-0002-8545-1251
Stéphanie BoireauInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
Franciane PaulDepartment of Clinical Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
David J YoungTranslational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD.ORCID 0000-0002-0885-8568
Sylvain LamureInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.ORCID 0000-0001-5980-305X
Raghavendra G MirmiraDepartment of Medicine, The University of Chicago, Chicago, IL.ORCID 0000-0002-5013-6075
Anupama NarlaDivision of Pediatric Hematology/Oncology, Stanford University, Stanford, CA.ORCID 0000-0003-2325-3388
Guillaume CartronInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.ORCID 0000-0003-0659-9635
Cynthia E DunbarTranslational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD.
Myriam Boyer-ClavelInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.
Natalie Porat-ShliomThoracic and GI Malignancies Branch, NCI, CCR, NIH, Bethesda, MD.ORCID 0000-0003-2676-8483
Valérie DardalhonInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.ORCID 0000-0003-0533-2920
Valérie S ZimmermannInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.ORCID 0000-0001-8919-0071
Marc SitbonInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.ORCID 0000-0003-3616-2338
Thomas E DeverSection on Protein Biosynthesis, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD.ORCID 0000-0001-7120-9678
Narla MohandasNew York Blood Center, New York, NY.ORCID 0000-0003-2271-5296
Lydie Da CostaLaboratory of Excellence GR-Ex, Paris, France.ORCID 0000-0001-8806-6941
Namrata D UdeshiProteomics Platform, Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA.ORCID 0000-0001-5312-1402
Lionel BlancFeinstein Institute for Medical Research, Manhasset, NY.ORCID 0000-0002-0185-6260
Sandrina KinetInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.ORCID 0000-0003-0699-108X
Naomi TaylorInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, Centre National de la Recherche Scientifique (CNRS), Montpellier, France.ORCID 0000-0002-2459-4558
National Institutes of Health · USInstitut de Génétique Moléculaire de Montpellier · FRCentre National de la Recherche Scientifique · FRBroad Institute · USNew York Blood Center · USUniversité de Montpellier · FRCentre Hospitalier Universitaire de Montpellier · FRFeinstein Institute for Medical Research · USInstitutt for Grafiske Medier · NOLaboratory of Excellence GR-Ex · FRNorthwell Health · USStanford University · USUniversité de Picardie Jules Verne · FRUniversity of Chicago · US

Funding

Mechanism and Regulation of Eukaryotic Protein SynthesisZIAHD001010 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI DEVER, THOMAS E · 2009 to 2025
$29.4M
YEAST MEMBRANE CYTOSKELETONP01DK032094 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NARLA, MOHANDAS · 1987 to 2021
$26.7M
Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Raghavendra G Mirmira · 2013 to 2026
$20.9M
Reprogramming hematopoietic stem cell (HSC) differentiation via metabolic conditZIABC011924 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TAYLOR, NAOMI · 2019 to 2025
$9.0M
Transcriptional Mechanisms Governing Beta Cell DifferentiationR01DK060581 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Raghavendra G Mirmira · 2002 to 2026
$8.5M
Novel therapies for bone marrow failure and Diamond-Blackfan AnemiaZIAHL006186 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DUNBAR, CYNTHIA E · 2014 to 2025
$5.7M
Role of Polyamines and Hypusine in Nutrient-Induced Beta-Cell Growth and ReplicationR01DK124906 · NIDDK · UNIVERSITY OF CHICAGO · PI Raghavendra G Mirmira · 2020 to 2026
$4.0M
Molecular targeting of erythroid progenitor cells in normal and disordered human erythropoiesisR01HL144436 · NHLBI · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI BLANC, LIONEL · 2019 to 2023
$2.5M
The Role of Erythroblastic Islands in Anemia of InflammationR01HL152099 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BLANC, LIONEL, KALFA, THEODOSIA ANASTASIOS · 2020 to 2023
$2.5M
Intramural NIH HHS ZIA BC011924Intramural NIH HHS ZIA HD001010NHLBI NIH HHS R01 HL144436NHLBI NIH HHS R01 HL152099NIDDK NIH HHS P01 DK032094NIDDK NIH HHS P30 DK020595NIDDK NIH HHS R01 DK060581NIDDK NIH HHS R01 DK124906
6 · The paper itself

Abstract

Metabolic programs contribute to hematopoietic stem and progenitor cell (HSPC) fate, but it is not known whether the metabolic regulation of protein synthesis controls HSPC differentiation. Here, we show that SLC7A1/cationic amino acid transporter 1-dependent arginine uptake and its catabolism to the polyamine spermidine control human erythroid specification of HSPCs via the activation of the eukaryotic translation initiation factor 5A (eIF5A). eIF5A activity is dependent on its hypusination, a posttranslational modification resulting from the conjugation of the aminobutyl moiety of spermidine to lysine. Notably, attenuation of hypusine synthesis in erythroid progenitors, by the inhibition of deoxyhypusine synthase, abrogates erythropoiesis but not myeloid cell differentiation. Proteomic profiling reveals mitochondrial translation to be a critical target of hypusinated eIF5A, and accordingly, progenitors with decreased hypusine activity exhibit diminished oxidative phosphorylation. This affected pathway is critical for eIF5A-regulated erythropoiesis, as interventions augmenting mitochondrial function partially rescue human erythropoiesis under conditions of attenuated hypusination. Levels of mitochondrial ribosomal proteins (RPs) were especially sensitive to the loss of hypusine, and we find that the ineffective erythropoiesis linked to haploinsufficiency of RPS14 in chromosome 5q deletions in myelodysplastic syndrome is associated with a diminished pool of hypusinated eIF5A. Moreover, patients with RPL11-haploinsufficient Diamond-Blackfan anemia as well as CD34+ progenitors with downregulated RPL11 exhibit a markedly decreased hypusination in erythroid progenitors, concomitant with a loss of mitochondrial metabolism. Thus, eIF5A-dependent protein synthesis regulates human erythropoiesis, and our data reveal a novel role for RPs in controlling eIF5A hypusination in HSPCs, synchronizing mitochondrial metabolism with erythroid differentiation.

Indexed as

ProteomicsSpermidineCell DifferentiationEukaryotic Translation Initiation Factor 5AHumansPeptide Initiation FactorsEukaryotic Translation Initiation Factor 5APeptide Initiation FactorsSpermidine

Identifiers

PMID36735910
PMCPMC10273172
OpenAlexW4319068312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.